RDS-04-010
RDS-04-010 is an atypical dopamine transporter (DAT) inhibitor. RDS-04-010 has the effect of inhibiting cocaine intake and seeking behavior. RDS-04-010 exerts its modulatory effect mainly by binding to the inward conformation of DAT, thereby reducing the reinforcing effect of cocaine. RDS-04-010 can be used in the study of cocaine use disorder (CUD) [1].
Product Specifications
CAS Number
[2324109-06-8]
UNSPSC
12352005
Target
Dopamine Transporter
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Purity
98.84
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC(C=C1)=CC=C1C(S(CCN2C[C@H](C)N(CC(C)O)[C@H](C)C2)=O)C3=CC=C(F)C=C3
Molecular Formula
C24H32F2N2O2S
Molecular Weight
450.58
References & Citations
[1]Soler-Cedeno O, et al. RDS-04-010: a novel atypical DAT inhibitor that inhibits cocaine taking and seeking and itself has low abuse potential in experimental animals. Transl Psychiatry. 2025 May 24;15 (1) :182.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2093984-01 0.1 mL
Biotin-Linked Polyclonal Antibody to Glutathione S Transferase Alpha 2 (GSTa2)
Ask
View Details MBS2093984-02 0.2 mL
Biotin-Linked Polyclonal Antibody to Glutathione S Transferase Alpha 2 (GSTa2)
Ask
View Details MBS2093984-03 0.5 mL
Biotin-Linked Polyclonal Antibody to Glutathione S Transferase Alpha 2 (GSTa2)
Ask
View Details MBS2093984-04 1 mL
Biotin-Linked Polyclonal Antibody to Glutathione S Transferase Alpha 2 (GSTa2)
Ask
View Details